(March 03 20:00) Forbes.com
Ultragenyx is a rare disease biotech company that researches and develops drugs for small populations of patients with high unmet medical needs. Since day one, Ultragenyx has been a purpose-built company with a huge vision: To lead the future of rare disease medicine.
You can find the original article
here